CN Stock MarketDetailed Quotes

600566 Hubei Jumpcan Pharmaceutical

Watchlist
  • 24.20
  • 0.000.00%
Market Closed Sep 13 15:00 CST
22.31BMarket Cap7.91P/E (TTM)

Hubei Jumpcan Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Hubei Jumpcan Pharmaceutical Q2 2024 Earnings Date

Currency：CNYAug 24, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
--
1.63B
--
-27.17%
Net Income
--
494.51M
--
-25.51%
Analyst Rating
Strong Buy

Sep 15, 2024

Hubei Jumpcan Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 10.860B--
--2024/FY-- / 10.042B--
--2023/FY9.655B / 10.055B--
--2022/FY8.996B / 8.582B--
--2021/FY7.631B / 7.233B--
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 10.860B--
--2024/FY-- / 10.042B--
--2023/FY9.655B / 10.055B--
--2022/FY8.996B / 8.582B--
--2021/FY7.631B / 7.233B--

Unlock Free Earnings Estimates

Hubei Jumpcan Pharmaceutical Earnings Reports

  • Hubei Jumpcan Pharmaceutical Co., Ltd. 2024 Semi-Annual Report

    Aug 23 12:00 ET

  • Summary of the 2024 interim report of Hubei Jumpcan Pharmaceutical Co., Ltd.

    Aug 23 12:00 ET

  • Hubei Jichuan Pharmaceutical Co., Ltd. Report for the first quarter of 2024

    Apr 19 12:00 ET

  • Summary of the 2023 Annual Report of Hubei Jichuan Pharmaceutical Co., Ltd.

    Apr 9 12:00 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Sep 15, 2024

    Strong Buy

    • Strong Buy

      87.50%

    • Buy

      12.50%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Latest Price
    % Chg

    No Data